How to store Liraglutide

A daily GLP-1 injection approved for weight management and type 2 diabetes.

Also called: Saxenda, Victoza, NN2211, Xultophy component.

GLP-1 / GIP / glucagon agonists · GLP-1 receptor agonist · Evidence: Approved drug.

Comes as: Saxenda/Victoza: 6 mg/mL ready-made solution in a 3 mL pen, 18 mg total, Xultophy: fixed insulin degludec/liraglutide solution in a pen.

Mixed with: None. Ready-made pens must not be diluted or mixed with other drugs..

The 18 mg total is pen content, not a powder-vial size.
Do not count clicks; use the marked dose counter. Do not share pens, even with a new needle.
No independently supported grey-vial water volume or after-mixing stability was found.

Before mixing: Unused pens: 2–8°C, protected from light. Never freeze.

After mixing: Saxenda/Victoza after first use: 30 days at 2–8°C or 15–30°C. Xultophy after first use: 21 days at 2–8°C or 15–30°C.

Related to Liraglutide

Semaglutide: A GLP-1 medicine with strong weight, glucose, heart and kidney evidence; dose and formulation matter.
Tirzepatide: A weekly GIP/GLP-1 injection with strong diabetes and weight-loss evidence and common stomach side effects.
Retatrutide: An experimental weekly injection with phase 3 weight-loss results.
Dulaglutide: A weekly GLP-1 medicine approved for type 2 diabetes and lower heart-event risk.
Exenatide: An older GLP-1 with twice-daily and weekly forms, now widely discontinued.

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.